NATURAL-HISTORY AND EPIDEMIOLOGY OF MALIGNANT MESOTHELIOMA

被引:88
作者
ANTMAN, KH
机构
[1] Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
关键词
D O I
10.1378/chest.103.4_Supplement.373S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Asbestos exposure constitutes the primary cause of pleural and peritoneal mesothelioma in humans. Risk relates to the duration and intensity of exposure. Thus, those exposed at younger ages are at higher lifetime risk. Families of asbestos workers exposed to asbestos on hair and clothing as well as to asbestos items brought home from the workplace are also at risk, as are employees working in the same vicinity as asbestos workers. The public health significance of exposure from asbestos in public and private buildings remains controversial. Malignant mesothelioma is difficult to diagnose and carries a poor prognosis. Chemotherapy with single or multiple agents has thus far been disappointing, but doxorubicin and cisplatin or mitomycin and cisplatin are probably most active with response rates in measurable disease of 25%. Palliative radiotherapy is also problematic since differences between tumor cytotoxicity and pulmonary tolerance are small and radiation pneumonitis may significantly impair quality of life.
引用
收藏
页码:S373 / S376
页数:4
相关论文
共 24 条
[1]   MALIGNANT MESOTHELIOMA - PROGNOSTIC VARIABLES IN A REGISTRY OF 180 PATIENTS, THE DANA-FARBER-CANCER-INSTITUTE AND BRIGHAM-AND-WOMENS-HOSPITAL EXPERIENCE OVER 2 DECADES, 1965-1985 [J].
ANTMAN, K ;
SHEMIN, R ;
RYAN, L ;
KLEGAR, K ;
OSTEEN, R ;
HERMAN, T ;
LEDERMAN, G ;
CORSON, J .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (01) :147-153
[2]  
ANTMAN KH, 1981, SEMIN ONCOL, V8, P313
[3]  
ANTMAN KH, 1985, LANCET, V2, P977
[4]   DIFFUSE MALIGNANT MESOTHELIOMA - PROSPECTIVE EVALUATION OF 69 PATIENTS [J].
CHAHINIAN, AP ;
PAJAK, TF ;
HOLLAND, JF ;
NORTON, L ;
AMBINDER, RM ;
MANDEL, EM .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (06) :746-755
[5]  
CONNELLY RR, 1987, JNCI-J NATL CANCER I, V78, P1053
[6]   THE PATHOGENESIS OF ASBESTOS-ASSOCIATED DISEASES [J].
CRAIGHEAD, JE ;
MOSSMAN, BT .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (24) :1446-1455
[7]  
GIBBS AR, 1990, BR J IND MED, V47, P921
[8]  
Hammond E C, 1979, Ann N Y Acad Sci, V330, P473, DOI 10.1111/j.1749-6632.1979.tb18749.x
[9]  
LEE KP, 1981, AM J PATHOL, V102, P314
[10]  
MCCORMACK PM, 1982, J THORAC CARDIOV SUR, V84, P834